Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Saudi Medical Journal. 2006; 27 (10): 1523-1525
em Inglês | IMEMR | ID: emr-80607

RESUMO

Production of fetal proteins by malignant tissue is a recognized phenomenon seen in many neoplastic disorders. Hence, the aim was to determine if there is a positive correlation between administration of chemotherapy and reduction in fetal hemoglobin [HbF] levels. In a prospective study at the University of Benin Teaching Hospital, Nigeria, 50 cancer patients at various stages of the disease and 50 controls for 10 months period [March to December, 2005], HbF was determined in pre- chemotherapy [n=23] and post-chemotherapy [n=27] cancer patients. Fetal hemoglobin was estimated by the modified Betke's method. A total of 20 patients [40%] comprising 10 pre-chemotherapy and 10 post-chemotherapy patients presented with increased HbF which was statistically significant [p<0.0001]. There was also a significant decrease in post- chemotherapy result when both pre and post-chemotherapy values were compared [p=0.0073]. The results presented indicate that during recovery of erythropoiesis some erythroblasts synthesized HbF and there was a reduction following administration of chemotherapy


Assuntos
Humanos , Masculino , Feminino , Neoplasias/sangue , Protocolos de Quimioterapia Combinada Antineoplásica/sangue , Estudos Prospectivos , Sedimentação Sanguínea/efeitos dos fármacos , Sedimentação Sanguínea/análise , Resultado do Tratamento , Hemoglobina Fetal/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA